SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Samuelsson H) "

Sökning: WFRF:(Samuelsson H)

  • Resultat 1-50 av 233
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Hemmingsson, Morten, et al. (författare)
  • Estimation of Electro-Mechanical Mode Parameters using Frequency Measurements
  • 2001
  • Ingår i: Power Engineering Society Winter Meeting, 2001. IEEE. - 0780366727 ; 3
  • Konferensbidrag (refereegranskat)abstract
    • Oscillation frequency and damping of electro-mechanical modes in a power system have traditionally been determined from events caused by large disturbances such as line switchings or generator tripping. Recent papers have shown the possibility to extract this information during normal operation from measurements of power through, or angle difference across, a transmission line. In this paper these methods are applied to frequency measurements from a 230 V wall-outlet. If accurate frequency and phase estimates can be obtained, this can be used for load control to damp electro-mechanical oscillations. Doing this in the distribution system is easier than in the transmission system. Using frequency for this has the advantage that this signal is available everywhere. It would thus be convenient if the estimation of modes and damping could be done in the distribution system. The results show that it is much harder to detect electro-mechanical mode information from frequency than from angle difference or power. However, it is possible to find the frequency of two electromechanical modes whereas the damping has too large an uncertainty. Fundamental problems when using frequency for mode estimation are further discussed
  •  
8.
  • Landin-Olsson, Mona, et al. (författare)
  • Immunoreactive trypsin(Ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls
  • 1990
  • Ingår i: Pancreas. - : Ovid Technologies (Wolters Kluwer Health). - 0885-3177. ; 5:3, s. 241-247
  • Tidskriftsartikel (refereegranskat)abstract
    • To evaluate the exocrine pancreatic function at the time of diagnosis of insulin-dependent diabetes mellitus, we determined immunoreactive an-odal and cathodal trypsin(ogen) levels in sera from almost all children (n = 375) 0-14 years of age in Sweden in whom diabetes developed during 1 year, and in sex-, age-, and geographically matched control subjects (n = 312). The median level of anodal trypsin(ogen) was 5 (quartile range, 3-7) µg/L in children with newly diagnosed diabetes, compared with a median level of 7 (quartile range, 4-8) µg/L in control subjects (p < 0.0001). Similarly, the median level of cathodal trypsin(ogen) was 8 (quartile range, 4-10) µg/L in children with diabetes, compared with a median level of 11 (quartile range, 7-15) µg/L in control subjects (p < 0.0001). The median of the individual ratios between cathodal and anodal trypsin(ogen) was 1.4 in the diabetic patients and 1.7 in the control children (p < 0.001). In a multivariate test, however, only the decrease in cathodal trypsin(ogen) concentration was associated with diabetes. The levels of trypsin(ogen)s did not correlate with levels of islet cell antibodies, present in 81% of the diabetic children. Several mechanisms may explain our findings, for example, similar pathogenetic factors may affect both the endocrine and exocrine pancreas simultaneously, a failing local trophic stimulation by insulin on the exocrine cells may decrease the trypsinogen production, and there may be an increased elimination of trypsin(ogen) because of higher filtration through the kidneys in the hyperglycemic state.
  •  
9.
  •  
10.
  •  
11.
  •  
12.
  •  
13.
  • Blomgren, E. M.V., et al. (författare)
  • Grey-box modeling for hot-spot temperature prediction of oil-immersed transformers in power distribution networks
  • 2023
  • Ingår i: Sustainable Energy, Grids and Networks. - 2352-4677. ; 34
  • Tidskriftsartikel (refereegranskat)abstract
    • Power transformers are one of the most costly assets in power grids. Due to increasing electricity demand and levels of distributed generation, they are more and more often loaded above their rated limits. Transformer ratings are traditionally set as static limits, set in a controlled environment with conservative margins. Through dynamic transformer rating, the rating is instead adapted to the actual working conditions of the transformers. This can help distribution system operators (DSOs) to unlock unused capacity and postpone costly grid investments. To this end, real-time information of the transformer operating conditions, and in particular of its hot-spot and oil temperature, is required. This work proposes a grey-box model that can be used for online estimation and forecasting of the transformer temperature. It relies on a limited set of non-intrusive measurements and was developed using experimental data from a DSO in Jutland, Denmark. The thermal model has proven to be able to predict the temperature of the transformers with a high accuracy and low computational time, which is particularly relevant for online applications. With a six-hour prediction horizon the mean average error was 0.4–0.6 °C. By choosing a stochastic data-driven modeling approach we can also provide prediction intervals and account for the uncertainty.
  •  
14.
  •  
15.
  •  
16.
  •  
17.
  •  
18.
  •  
19.
  •  
20.
  • Jonsdottir, Berglind, et al. (författare)
  • Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents
  • 2013
  • Ingår i: Diabetologia. - : Springer Verlag (Germany). - 0012-186X .- 1432-0428. ; 56:8, s. 1735-1742
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim of this work was to investigate, in children newly diagnosed with type 1 diabetes: (1) the prevalence of autoantibodies against thyroid peroxidase (TPOAb) and thyroglobulin (TGAb); and (2) the association between TPOAb, TGAb or both, with either islet autoantibodies or HLA-DQ genes. less thanbrgreater than less thanbrgreater thanBlood samples from 2,433 children newly diagnosed with type 1 diabetes were analysed for TPOAb and TGAb in addition to autoantibodies against arginine zinc transporter 8 (ZnT8RA), tryptophan zinc transporter 8 (ZnT8WA), glutamine zinc transporter 8 (ZnT8QA), glutamic acid decarboxylase (GADA), insulin (IAA), insulinoma-associated protein-2 (IA-2A), HLA-DQA-B1 genotypes, thyroid-stimulating hormone (TSH) and free thyroxine (T4). less thanbrgreater than less thanbrgreater thanAt type 1 diabetes diagnosis, 12% of the children had thyroid autoantibodies (60% were girls; p andlt; 0.0001). GADA was positively associated with TPOAb (p andlt; 0.001) and with TGAb (p andlt; 0.001). In addition, ZnT8A was associated with both TPOAb (p = 0.039) and TGAb (p = 0.015). DQB1*05:01 in any genotype was negatively associated with TPOAb (OR 0.55, 95% CI 0.37, 0.83, p value corrected for multiple comparisons (p (c)) = 0.012) and possibly with TGAb (OR 0.55, 95% CI 0.35, 0.87, p (c) = 0.07). Thyroid autoimmunity in children newly diagnosed with type 1 diabetes was rarely (0.45%) associated with onset of clinical thyroid disease based on TSH and free T4. less thanbrgreater than less thanbrgreater thanGADA and ZnT8A increased the risk for thyroid autoimmunity at the time of clinical diagnosis of type 1 diabetes, while HLA-DQB1*05:01 reduced the risk. However, the associations between thyroid autoimmunity and HLA-DQ genotype were weak and did not fully explain the co-occurrence of islet and thyroid autoimmunity.
  •  
21.
  •  
22.
  •  
23.
  • Le Blanc, K., et al. (författare)
  • Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
  • 2007
  • Ingår i: Leukemia. - : Springer Science and Business Media LLC. - 0887-6924 .- 1476-5551. ; 21:8, s. 1733-1738
  • Tidskriftsartikel (refereegranskat)abstract
    • Seven patients underwent treatment with mesenchymal stem cells (MSCs), together with allogeneic hematopoietic stem cell transplantation (HSCT). MSCs were given to three patients for graft failure and four patients were included in a pilot study. HSCT donors were three human leukocyte antigen (HLA)-identical siblings, three unrelated donors and one cord blood unit. The conditioning was myeloablative in four patients and reduced in three patients. MSC donors were HLA-identical siblings in three cases and haploidentical in four cases. Neutrophil counts >0.5 ×109/l was reached at a median of 12 (range 10-28) days. Platelet counts >30 x 109/l was achieved at a median of 12 (8-36) days. Acute graft-versus-host disease (GVHD) grade 0-l was seen in five patients. Two patients developed grade II, which in one patient evolved into chronic GVHD. One severe combined immunodeficiency (SCID) patient died of aspergillosis, the others are alive and well. One patient, diagnosed with aplastic anemia had graft failure after her first transplantation and severe Henoch-Schönlein Purpura (HSP). After retransplantation of MSCs and HSCs, she recovered from both the HSP and aplasia. Thus, co-transplantation of MSC resulted in fast engraftment of absolute neutrophil count (ANC) and platelets and 100% donor chimerism, even in three patients regrafted for graft failure/rejection.
  •  
24.
  •  
25.
  •  
26.
  •  
27.
  •  
28.
  • Samuelsson, J., et al. (författare)
  • A phase II trial of pegylated interferon a-2b therapy for polycythemia vera and essential thrombocythemia : Feasibility, clinical and biologic effects, and impact on quality of life
  • 2006
  • Ingår i: Cancer. - : Wiley. - 0008-543X .- 1097-0142. ; 106:11, s. 2397-2405
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND. Conventional interferon-a (IFN) is an effective treatment for patients with myeloproliferative disorders. However, many patients discontinue therapy because of side effects. METHODS. In this 24-month, Phase II feasibility study of pegylated interferon a-2b (PEG-IFN) treatment, a starting dose of 0.5 µg/kg per week was received by 21 patients with polycythemia vera (PV) and 21 patients with essential thrombocythemia (ET). The treatment objective, a complete platelet response (CR), was a platelet count <400 × 109/L in symptomatic patients and <600 in asymptomatic patients. Neutrophil polycythemia rubra vera-1 (PRV-1) messenger RNA expression was analyzed prior to and during therapy. Quality of life (QoL) was investi-gated by using the European Organization for Research and Treatment of Cancer QLQ-C30 questionnaire. RESULTS. At 6 months, 29 of 42 patients (69%) had achieved a CR after a median of 83 days. The CR rate was not related to diagnosis, gender, or previous therapy. Nineteen patients completed the planned 2-year treatment in CR. No thromboembolic or bleeding complications were observed. Phlebotomy requirements were reduced in the majority of patients with PV. Five of 14 patients (36%) who initially were positive for PRV-1 achieved normalized PRV-1 expression under PEG-IFN treatment. Side effects were the cause of therapy failure in 16 of 23 patients. However, only 8 of 19 patients reported any side effects at 2 years. The QLQ-C30 revealed clinically significant impairments in several aspects of QoL at 6 months, however, at 2 years, QoL measurements were not different from baseline. CONCLUSIONS. PEG-IFN effectively reduced platelet counts in 29 of 42 patients, but only 19 patients maintained a CR at 2 years. The reversal of PRV-1 positivity noted in a subset of patients suggested that PEG-IFN may have an effect on the malignant clone. PEG-IFN is a valuable therapeutic alternative for patients who tolerate its initial side effects. © 2006 American Cancer Society.
  •  
29.
  •  
30.
  • Samuelsson, K, et al. (författare)
  • [Not Available]
  • 2015
  • Ingår i: Lakartidningen. - 1652-7518. ; 112
  • Tidskriftsartikel (refereegranskat)
  •  
31.
  •  
32.
  •  
33.
  • Scheutz, C., et al. (författare)
  • Mitigation of methane emission from an old unlined landfill in Klintholm, Denmark using a passive biocover system
  • 2014
  • Ingår i: Waste Management. - : Elsevier BV. - 0956-053X .- 1879-2456. ; 34:7, s. 1179-1190
  • Tidskriftsartikel (refereegranskat)abstract
    • Methane generated at landfills contributes to global warming and can be mitigated by biocover systems relying on microbial methane oxidation. As part of a closure plan for an old unlined landfill without any gas management measures, an innovative biocover system was established. The system was designed based on a conceptual model of the gas emission patterns established through an initial baseline study. The study included construction of gas collection trenches along the slopes of the landfill where the majority of the methane emissions occurred. Local compost materials were tested as to their usefulness as bioactive methane oxidizing material and a suitable compost mixture was selected. Whole site methane emission quantifications based on combined tracer release and downwind measurements in combination with several local experimental activities (gas composition within biocover layers, flux chamber based emission measurements and logging of compost temperatures) proved that the biocover system had an average mitigation efficiency of approximately 80%. The study showed that the system also had a high efficiency during winter periods with temperatures below freezing. An economic analysis indicated that the mitigation costs of the biocover system were competitive to other existing greenhouse gas mitigation options. (C) 2014 Elsevier Ltd. All rights reserved.
  •  
34.
  • Simmen, K. A., et al. (författare)
  • Macrocylic inhibitors of hepatitis C virus
  • 2012
  • Patent (populärvet., debatt m.m.)abstract
    • Inhibitors of HCV replication of formula (I)and the N-oxides, salts, and stereoisomers, whereineach dashed line represents an optional double bond;X is N, CH and where X bears a double bond it is C;R1 is —OR7, —NH—SO2R8;R2 is hydrogen, and where X is C or CH, R2 may also be C1-6alkyl;R3 is hydrogen, C1-6alkyl, C1-6alkoxyC1-6alkyl, C3-7cycloalkyl;R4 is aryl or Het; n is 3, 4, 5, or 6;R5 is halo, C1-6alkyl, hydroxy, C1-6alkoxy, phenyl, or Het;R6 is C1-6alkoxy, or dimethylamino;R7 is hydrogen; aryl; Het; C3-7cycloalkyl optionally substituted with C1-6alkyl; or C1-6alkyl optionally substituted with C3-7cycloalkyl, aryl or with Het;R8 is aryl; Het; C3-7cycloalkyl optionally substituted with C1-6alkyl; or C1-6alkyl optionally substituted with C3-7cycloalkyl, aryl or with Het;aryl is phenyl optionally substituted with one, two or three substituents;Het is a 5 or 6 membered saturated, partially unsaturated or completely unsaturated heterocyclic ring containing 1 to 4 heteroatoms selected from nitrogen, oxygen and sulfur, and being optionally substituted with one, two or three substituents;pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
  •  
35.
  •  
36.
  • Spanbroek, R, et al. (författare)
  • Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis
  • 2003
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - : Proceedings of the National Academy of Sciences. - 0027-8424. ; 100:3, s. 1238-1243
  • Tidskriftsartikel (refereegranskat)abstract
    • Oxidation products of low-density lipoproteins have been suggested to promote inflammation during atherogenesis, and reticulocyte-type 15-lipoxygenase has been implicated to mediate this oxidation. In addition, the 5-lipoxygenase cascade leads to formation of leukotrienes, which exhibit strong proinflammatory activities in cardiovascular tissues. Here, we studied both lipoxygenase pathways in human atherosclerosis. The 5-lipoxygenase pathway was abundantly expressed in arterial walls of patients afflicted with various lesion stages of atherosclerosis of the aorta and of coronary and carotid arteries. 5-lipoxygenase localized to macrophages, dendritic cells, foam cells, mast cells, and neutrophilic granulocytes, and the number of 5-lipoxygenase expressing cells markedly increased in advanced lesions. By contrast, reticulocyte-type 15-lipoxygenase was expressed at levels that were several orders of magnitude lower than 5-lipoxygenase in both normal and diseased arteries, and its expression could not be related to lesion pathology. Our data support a model of atherogenesis in which 5-lipoxygenase cascade-dependent inflammatory circuits consisting of several leukocyte lineages and arterial wall cells evolve within the blood vessel wall during critical stages of lesion development. They raise the possibility that antileukotriene drugs may be an effective treatment regimen in late-stage disease.
  •  
37.
  • Svanborg, Catharina, et al. (författare)
  • The 'innate' host response protects and damages the infected urinary tract
  • 2001
  • Ingår i: Annals of Medicine. - 1365-2060. ; 33:9, s. 563-570
  • Tidskriftsartikel (refereegranskat)abstract
    • Symptoms of infection and tissue pathology are caused by the host response; not by the microbe per se. The same response is also critical for the defence and is needed to clear infection. It is therefore essential to understand how the host response is activated and to identify the critical effector mechanisms of the defence. We have studied these issues in the urinary tract infection (UTI) model. The symptoms of UTI and the host defence both rely on the so-called 'innate' immune system, making this one of the best characterized human disease models of 'innate immunity. We discuss the critical molecular events that determine whether the host response will be activated by P-fimbriated uropathogenic Escherichia coli as well as factors determining whether the patient develops acute pyelonephritis or asymptomatic bacteriuria. We will describe the glycoconjugate receptors used by the P-fimbriated bacteria adhering to host tissues, the recruitment of TLR4 co-receptors and the signalling pathways that allow progression to symptomatic disease, and discuss how these mechanisms are altered in asymptomatic carriers, presenting the possible genetic basis for unresponsiveness. We have shown that neutrophils are the critical effectors of the host defence and that neutrophil dysfunctions lead to acute pyelonephritis and renal scarring. Here we discuss the mechanisms of neutrophil-mediated, chemokine receptor (CXCR1)-dependent clearance, and the defect in interleukin-8 receptor homolog knock-out (IL-8Rh KO) mice and describe the data linking low CXCR1 expression to recurrent pyelonephritis in man, as well as the information on the genetic basis for low CXCR1 expression in affected patients. Finally, the mechanisms of renal scarring in IL8Rh KO mice will be discussed in relation to human disease. Our studies hold the promise to provide a molecular and genetic explanation for disease susceptibility in some patients with UTI and to offer more precise tools for the diagnosis and therapy of these infections.
  •  
38.
  •  
39.
  • van Eck, C. F., et al. (författare)
  • "Anatomic" anterior cruciate ligament reconstruction: a systematic review of surgical techniques and reporting of surgical data
  • 2010
  • Ingår i: Arthroscopy. - : Elsevier BV. - 1526-3231. ; 26:9 Suppl
  • Tidskriftsartikel (refereegranskat)abstract
    • PURPOSE: The aim of this systematic review was to evaluate studies published on anatomic double-bundle anterior cruciate ligament (ACL) reconstruction. METHODS: A systematic electronic search was performed by use of the Medline and Embase databases. Studies that were published from January 1995 to April 2009 were included. The selection criteria were studies that reported on a surgical technique for "anatomic double-bundle ACL reconstruction" on skeletally mature living human subjects and were written in English. Data collected and analyzed included a variety of surgical data. Tables were created to provide an overview of surgical techniques for anatomic ACL reconstruction. RESULTS: Seventy-four studies were included in this review. Some surgical factors were adequately reported in the majority of the articles: visualizing the native ACL insertion sites, placing the tunnels in the footprint, graft type, and fixation method. However; ACL insertion site measurement, femoral intercondylar notch measurement, individualization of surgery, and intraoperative/postoperative imaging were poorly reported. The most variety was seen in knee flexion angle during femoral tunnel drilling and tensioning pattern of the grafts. CONCLUSIONS: For most surgical data, there was a gross under-reporting of specific operative technique data. We believe that the details of an "anatomic" operative technique are crucial for the valid interpretations of the outcomes. Thus we encourage authors to report their surgical technique in a specific and standardized fashion.
  •  
40.
  • Ahldén, Mattias, et al. (författare)
  • Rotatory knee laxity.
  • 2013
  • Ingår i: Clinics in sports medicine. - : Elsevier BV. - 1556-228X .- 0278-5919. ; 32:1, s. 37-46
  • Tidskriftsartikel (refereegranskat)abstract
    • Evaluation of injured-knee laxity is essential for treatment selection, clinical follow-up, and research. Interest in rotatory knee laxity increased with implementation of anatomic anterior cruciate ligament reconstruction. The pivot shift test represents a link between static testing with 1° of freedom and dynamic testing during functional activity. Difficulties lie in standardizing the performance of the pivot shift test and extracting measurable and relevant kinematic data. Noninvasive methodologies based on electromagnetic or acceleration sensors can evaluate the pivot shift in a quantitative and reliable manner. Further validation and reliability testing of devices for examination of rotatory laxity is warranted.
  •  
41.
  •  
42.
  • Alentorn-Geli, Eduard, et al. (författare)
  • Factors predictive of poorer outcomes in the surgical repair of multiligament knee injuries.
  • 2019
  • Ingår i: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA. - : Springer Science and Business Media LLC. - 1433-7347. ; 27:2, s. 445-459
  • Tidskriftsartikel (refereegranskat)abstract
    • To investigate the influence of injury and treatment factors on clinical/functional outcomes in multiligament knee injuries (MLKI).Thirty-nine consecutive patients with confirmed and surgically treated MLKI who met inclusion criteria were scheduled for a follow-up visit to obtain: SF-12 and subjective feeling of normalcy between the operated and healthy knee, and IKDC, active range of motion (ROM), and stability exam (Lachman test, posterior drawer, and dial test at 30°). A chart review was used to obtain data on injury and treatment factors.The postoperative mean (SD) outcomes were: IKDC score 62.7 (25.9), flexion-extension ROM 125° (29°), and percentage of normalcy 74% (20%). The postoperative normal/nearly normal stability exam was: Lachman test 36 (95%) patients, posterior drawer at 90° 38 (97%) patients, and dial test of 39 (100%) patients. There were 24 (61.5%) and 23 (59%) patients with complications and reoperations, respectively. The presence of bicruciate injuries was associated with worse Lachman (p=0.03) and posterior drawer tests (p=0.03). Presence of injury to meniscal structures was associated with worse Lachman test (p=0.03), lower percentage of normalcy (p=0.02) and extension lag (p=0.04). Injury to cartilage structures was associated with worse IKDC scores (p=0.04). IKDC was lower in cases of posterolateral corner reconstruction (p=0.03) and use of allograft tendons for reconstruction (p=0.02); ROM was lower in allograft reconstruction (p=0.02) and need for meniscal repair (p = 0.01). Bicruciate reconstruction led to worst posterior drawer test (p=0.006).The outcomes of MLKI might be negatively influenced by bicruciate ligament, meniscal, and cartilage injuries; with regards to treatment characteristics, need for posterolateral corner or bicruciate ligament reconstruction, use of allografts, or need for meniscal repair may similarly diminish outcomes. While surgical treatment provides good overall function, ROM and stability, it rarely results in a "normal" knee and the chances of complications and reoperations are high.Cross-sectional comparative study, Level III.
  •  
43.
  •  
44.
  • Andersen, J. K., et al. (författare)
  • Quantification of Greenhouse Gas Emissions from Windrow Composting of Garden Waste
  • 2010
  • Ingår i: Journal of Environmental Quality. - : Wiley. - 0047-2425. ; 39:2, s. 713-724
  • Tidskriftsartikel (refereegranskat)abstract
    • Microbial degradation of organic wastes entails the production of various gases such as carbon dioxide (CO2), methane (CH4), nitrous oxide (N2O), and carbon monoxide (CO). Some of these gases are classified as greenhouse gases (GHGs), thus contributing to climate change. A study was performed to evaluate three methods for quantifying GHG emissions from central composting of garden waste. Two small-scale methods were used at a windrow composting facility: a static flux chamber method and a funnel method. Mass balance calculations based on measurements of the C content in the in- and out-going material showed that 91 to 94% of the C could not be accounted for using the small-scale methods, thereby indicating that these methods significantly underestimate GHG emissions. A dynamic plume method (total emission method) employing Fourier Transform Infra Red (FTIR) absorption spectroscopy was found to give a more accurate estimate of the GHG emissions, with CO2 emissions measured to be 127 +/- 15% of the degraded C. Additionally, with this method, 2.7 +/- 0.6% and 0.34 +/- 0.16% of the degraded C was determined to be emitted as CH4 and CO. In this study, the dynamic plume method was a more effective tool for accounting for C losses and, therefore, we believe that the method is Suitable for measuring GHG emissions from composting facilities. The total emissions were found to be 2.4 +/- 0.5 kg CH4-C Mg-1 wet waste (ww) and 0.06 +/- 0.03 kg N2O-N Mg-1 ww from a facility treating 15,540 Mg of garden waste yr(-1), or 111 +/- 30 kg CO2-equivalents Mg-1 ww.
  •  
45.
  • Andersson, C, et al. (författare)
  • Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes
  • 2013
  • Ingår i: Pediatric Diabetes. - : Wiley-Blackwell. - 1399-543X .- 1399-5448. ; 14:2, s. 97-105
  • Tidskriftsartikel (refereegranskat)abstract
    • Andersson C, Vaziri-Sani F, Delli AJ, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson SA, Lernmark A, Elding Larsson H, the BDD Study group. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatric Diabetes 2013: 14: 97-105. Objective To establish the diagnostic sensitivity of and the relationships between autoantibodies to all three Zinc transporter 8 (Zinc transporter 8 autoantibody to either one, two, or all three amino acid variants at position 325, ZnT8A) variants to human leukocyte antigen (HLA)-DQ and to autoantibodies to glutamic acid decarboxylase (GADA), insulinoma-associated protein 2 (IA-2A), and insulin (IAA). Methods We analyzed 3165 patients with type 1 diabetes (T1D) in the Better Diabetes Diagnosis study for HLA-DQ genotypes and all six autoantibodies (ZnT8RA, arginine 325 Zinc transporter 8 autoantibody; ZnT8WA, tryptophan 325 Zinc transporter 8 autoantibody; ZnT8QA, glutamine 325 Zinc transporter 8 autoantibody; GADA, IA-2A, and IAA). Results ZnT8A was found in 65% of the patients and as many as 108 of 3165 (3.4%) had 13 ZnT8A alone. None had ZnT8QA alone. Together with GADA (56%), IA-2A (73%), and IAA (33%), 93% of the T1D patients were autoantibody positive. All three ZnT8A were less frequent in children below 2 yr of age (pandlt;0.0001). All three ZnT8A were associated with DQA1-B1*X-0604 (DQ6.4) and DQA1-B1*03-0302 (DQ8). ZnT8WA and ZnT8QA were negatively associated with DQA1-B1*05-02 (DQ2). Conclusions Analysis of ZnT8A increased the diagnostic sensitivity of islet autoantibodies for T1D as only 7% remained islet autoantibody negative. The association between DQ6.4 and all three ZnT8A may be related to ZnT8 antigen presentation by the DQ6.4 heterodimer.
  •  
46.
  • Andersson, H.O., et al. (författare)
  • Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors
  • 2003
  • Ingår i: European Journal of Biochemistry. - : Wiley. - 0014-2956 .- 1432-1033. ; 270:8, s. 1746-1758
  • Tidskriftsartikel (refereegranskat)abstract
    • HIV-1 protease is an important target for treatment of AIDS, and efficient drugs have been developed. However, the resistance and negative side effects of the current drugs has necessitated the development of new compounds with different binding patterns. In this study, nine C-terminally duplicated HIV-1 protease inhibitors were cocrystallised with the enzyme, the crystal structures analysed at 1.8-2.3 Å resolution, and the inhibitory activity of the compounds characterized in order to evaluate the effects of the individual modifications. These compounds comprise two central hydroxy groups that mimic the geminal hydroxy groups of a cleavage-reaction intermediate. One of the hydroxy groups is located between the d-oxygen atoms of the two catalytic aspartic acid residues, and the other in the gauche position relative to the first. The asymmetric binding of the two central inhibitory hydroxyls induced a small deviation from exact C2 symmetry in the whole enzyme-inhibitor complex. The study shows that the protease molecule could accommodate its structure to different sizes of the P2/P2' groups. The structural alterations were, however, relatively conservative and limited. The binding capacity of the S3/S3' sites was exploited by elongation of the compounds with groups in the P3/P3' positions or by extension of the P1/P1' groups. Furthermore, water molecules were shown to be important binding links between the protease and the inhibitors. This study produced a number of inhibitors with Ki values in the 100 picomolar range.
  •  
47.
  • Anderzen, J., et al. (författare)
  • International benchmarking in type 1 diabetes: Large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study
  • 2020
  • Ingår i: Pediatric Diabetes. - : Hindawi Limited. - 1399-543X .- 1399-5448. ; 21:4, s. 621-627
  • Tidskriftsartikel (refereegranskat)abstract
    • Objectives To identify differences and similarities in HbA1c levels and patterns regarding age and gender in eight high-income countries. Subjects 66 071 children and adolescents below18 years of age with type 1 diabetes for at least 3 months and at least one HbA1c measurement during the study period. Methods Pediatric Diabetes Quality Registry data from Austria, Denmark, England, Germany, Norway, Sweden, the United States, and Wales were collected between 2013 and 2014. HbA1c, gender, age, and duration were used in the analysis. Results Distribution of gender and age groups was similar in the eight participating countries. The mean HbA1c varied from 60 to 73 mmol/mol (7.6%-8.8%) between the countries. The increase in HbA1c between the youngest (0-9 years) to the oldest (15-17 years) age group was close to 8 mmol/mol (0.7%) in all countries (P < .001). Females had a 1 mmol/mol (0.1%) higher mean HbA1c than boys (P < .001) in seven out of eight countries. Conclusions In spite of large differences in the mean HbA1c between countries, a remarkable similarity in the increase of HbA1c from childhood to adolescence was found.
  •  
48.
  •  
49.
  • Astell, A. J., et al. (författare)
  • INLIFE - Independent Living Support Functions for the Elderly: Technology and Pilot Overview
  • 2018
  • Ingår i: INTELLIGENT ENVIRONMENTS 2018. - 9781614998747 - 9781614998730 ; , s. 526-535
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)abstract
    • In this paper, we present the European H2020 project INLIFE (INdependent LIving support Functions for the Elderly). The project brought together 20 partners from nine countries with the goal of integrating into a common ICT platform a range of technologies intended to assist community-dwelling older people with cognitive impairment. The majority of technologies existed prior to INLIFE and a key goal was to bring them together in one place along with a number of new applications to provide a comprehensive set of services. The range of INLIFE services fell into four broad areas: Independent Living Support, Travel Support, Socialization and Communication Support and Caregiver Support. These included security applications, services to facilitate interactions with formal and informal caregivers, multilingual conversation support, web-based physical exercises, teleconsultations, and support for transport navigation. In total, over 2900 people participated in the project; they included elderly adults with cognitive impairment, informal caregivers, healthcare professionals, and other stakeholders. The aim of the study was to assess whether there was improvement/stabilization of cognitive/emotional/physical functioning, as well as overall well-being and quality of life of those using the INLIFE services, and to assess user acceptance of the platform and individual services. The results confirm there is a huge interest and appetite for technological services to support older adults living with cognitive impairment in the community. Different services attracted different amounts of use and evaluation with some proving extremely popular while others less so. The findings provide useful information on the ways in which older adults and their families, health and social care services and other stakeholders wish to access technological services, what sort of services they are seeking, what sort of support they need to access services, and how these services might be funded.
  •  
50.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-50 av 233
Typ av publikation
tidskriftsartikel (178)
konferensbidrag (38)
bokkapitel (7)
rapport (4)
forskningsöversikt (2)
patent (2)
visa fler...
annan publikation (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (187)
övrigt vetenskapligt/konstnärligt (43)
populärvet., debatt m.m. (3)
Författare/redaktör
Samuelsson, B (28)
Samuelsson, J (26)
Samuelsson, Kristian ... (19)
Paoletti, R. (13)
Sinzinger, H (12)
Vane, JR (12)
visa fler...
Ramwell, P (12)
Wong, PYK (12)
Breimer, Michael, 19 ... (12)
Karlsson, Jón, 1953 (10)
Fu, Freddie H (10)
Birgegård, Gunnar (9)
Andreasson, B (9)
Samuelsson, Ulf (9)
Lindholm, Lars H (9)
Samuelsson, K. (8)
Johansson, P. (7)
Samuelsson, EB (7)
Harrison, C (7)
Samuelsson, Ola (7)
Carlberg, Bo (7)
Samuelsson, Jan (6)
Bjorkholm, M (6)
Musahl, Volker (6)
Sundstrom, E (6)
Samuelsson, Olof (6)
Reiter, A (6)
Zweegman, S (6)
Cervantes, F (6)
Besses, C (6)
Hellstrom-Lindberg, ... (6)
Barbui, T (6)
Barosi, G. (6)
Mesa, R (6)
Passamonti, F (6)
Sun, X. (5)
Xu, Z. (5)
Lehmann, T. (5)
Zhang, P (5)
Xu, J (5)
Ferrari, M (5)
Press, R (5)
Magnusson, M (5)
Samuelsson, Tore, 19 ... (5)
Hansson, Gunnar C., ... (5)
Samuelsson, A (5)
Lofvenberg, E (5)
Radmark, O (5)
Samuelsson, M (5)
Kiladjian, J-J (5)
visa färre...
Lärosäte
Karolinska Institutet (94)
Göteborgs universitet (62)
Uppsala universitet (35)
Linköpings universitet (29)
Lunds universitet (27)
Umeå universitet (16)
visa fler...
Kungliga Tekniska Högskolan (7)
Chalmers tekniska högskola (7)
Stockholms universitet (6)
Luleå tekniska universitet (5)
Örebro universitet (4)
Linnéuniversitetet (3)
Jönköping University (1)
Mittuniversitetet (1)
Södertörns högskola (1)
Naturhistoriska riksmuseet (1)
Sophiahemmet Högskola (1)
IVL Svenska Miljöinstitutet (1)
visa färre...
Språk
Engelska (227)
Svenska (6)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (88)
Teknik (21)
Naturvetenskap (19)
Samhällsvetenskap (7)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy